mshealthcare > Anti_cancer

Category: Anti_cancer

Anti-cancer vaccines represent a promising and evolving field in oncology. By harnessing the body’s immune system, they offer a targeted and potentially long-lasting approach to cancer prevention and treatment.

Posted on:

BRYXTA 100 ML INJECTION VIAL: PATEINT GUIDE FOR CANCER TREATMENT

Bryxta 100 mg/4 ml injection is a targeted cancer therapy medication containing Bevacizumab , used to treat various cancers, including colorectal, non-small cell lung ,kidney ,ovarian and cervical cancers. It inhibits tumor growth by blocking vascular endothelial growth factor (VEGF) ,which prevents the formation of new blood vessels that feed tumors. It is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer ,kidney cancer ,cervical cancer ,epithelial ovarian, Fallopian tube or primary peritoneal cancer ,cancer of colon and rectum.

 

WHY IS TARGETED THERAPY IMPORTANT IN CANCER TREATMENT?

Targeted therapies are crucial in modern cancer treatment by offering precision medicine that attacks specific genetic mutations or proteins driving tumor growth , rather than killing all rapidly dividing cells like chemotherapy . this approach improves survival rates -often extending life beyond 5 years for advanced cancers -while causing fewer side effects and improving quality of life. These therapies specifically identify and disrupt cancer cells, sparing most healthy cells from damage.

Targeted therapies work by blocking signals that tell cancer cells to grow, inhibiting new blood vessel formation and delivering toxins directly to cancer cells. They are used based on the molecular profiling of tumor, often enabling treatment when conventional chemotherapy fails. When a cure is not possible, targeted therapies can often manage cancer as a chronic, stable disease.

 

WHAT IS BRYXTA?

Bryxta is a bio similar bevacizumab (400 mg/100 mg) manufactured by Zydus life sciences ,used as an anti-cancer (oncology) injection to treat various cancers like lung, colorectal, breast and ovarian cancer. It acts by inhibiting VEGF to stop tumor blood supply . it is a prescription-only, refrigerated injection administered by healthcare professionals.

It is a targeted anticancer ,vascular endothelial growth factor (VEGF) inhibitor, classified as a recombinant humanized monoclonal antibody. It works by binding to VEGF to prevent the formation of new blood vessels that feed tumor growth.

Key classification:

  • Active ingredient: Bevacizumab
  • Therapeutic class: anti -neoplastic agent (anti-cancer)
  •  Pharmacological class: VEGF Inhibitor /anti-androgenic agent
  • Mechanism of action: monoclonal antibody that inhibits VEGF, ‘’starving’’ tumors of nutrients and oxygen.
  •  Schedule : schedule H (prescription only)
  • Administration: intravenous (IV) infusion only, administered by a healthcare professional.

 Mechanism of action: Bryxta is used in treating various cancers ,including metastatic colorectal cancer, non-squamous non-small cell lung cancer ,galioblastoma and renal cell-carcinoma.

 

WHAT ARE THE MEDICAL USES OF BRYXTA INJECTION?

Baryxta is a targeted cancer therapy used to treat various advanced cancers-including colorectal, non-small cell lung cancer ,kidney ,ovarian ,cervical and brain -by inhibiting blood vessel growth to tumors . it is typically administered via intravenous infusion alongside chemotherapy to slow cancer progression.

 

Following are the medical uses of Baryxta injection(bevacizumab)

1. Treatment of colorectal cancer

Bryxta injection is a targeted immunotherapy used to treat metastatic colorectal cancer by inhibiting vascular endothelial growth factor (VEGF) ,which starves tumors of blood supply. It is administered via intravenous infusion in combination with fluropyrimidine-based chemotherapy. It is crucial for treating advanced , spreading cancers. It is not a self-injection, it must be administered by a qualified healthcare professional in clinic or hospital setting.

2. Treatment of lung cancer

Bryxta injection is a targeted therapy used to treat advanced non-small cell lung cancer (NSCLC) by inhibiting tumor blood vessel growth . usually paired with chemotherapy, it helps shrinks tumors or slow their progression . it is administered via infusion in a hospital setting. It is used in combination with platinum-based chemotherapy for advanced or metastatic NSCCL.

3. Treatment of kidney cancer

Bryxta injection is an anti-cancer, anti-androgenic medication used in treating various cancers, including kidney cancer by restricting the blood supply required for tumor growth.it works by inhibiting VEGF, usually administered via intravenous infusion in combination with other treatments by a healthcare professional. It is used as a part of combination therapy for treating kidney cancer , particularly metastatic or advanced cases. It must be administrated by a qualified healthcare professional in a hospital or clinic setting via an iv infusion.

4. Treatment of cervical and ovarian cancers

Bryxta injection is an anti-androgenic targeted therapy used for advanced cervical cancers by inhibiting tumor blood supply. In combination with chemotherapy, it is indicated for persistent/recurrent/metastatic cervical cancer and platinum-sensitive /resistant ovarian cancer. It is administered via iv infusion by healthcare professionals.

5. Often used in combination with chemotherapy

Bryxta injection is a prescription anti-angiogenic medication used in combination with platinum-based or other chemotherapy regimes to treat various advanced cancers, including non-small cell lung cancer (NSCLC) ,colorectal ,ovarian ,cervical and kidney cancers.it act by inhibiting VEGF to starve tumors of blood supply, improving survival rates when paired with chemotherapy. It is not a chemotherapy agent itself, but an immunotherapy that boost the efficacy of chemotherapy.

 

WHAT ARE THE BENEFITS OF BRYXTA 100 ML INJECTION?

Bryxta 100 mg injection is a targeted anti-cancer therapy that inhibits the growth of new blood vessels (angiogenesis) to tumors, effectively starving them of nutrients and oxygen. It is primarily used to treat various advanced cancers, including colon, rectum,lung ,kidney, brain ,cervical and ovarian cancers.

Benefits of Bryxta 100 ml injection are:

1. Slows tumor growth by blocking blood vessel formation

Bryxta 100 mg injection is an anti-cancer medication that contains Bevacizumb . it is used to treat various advanced cancers by stopping the growth of new blood vessels that feed the tumor. By blocking the vascular Endothelial Growth Factor (VEGF) protein, bryxta starves cancer cells of necessary nutrients and oxygen ,causing the tumor to shrink or cease development. It is not recommended for use in pregnant women as it can harm the fetus, and effective contraception must be used for six months after treatment.

2. Enhances effectiveness of chemotherapy

Bryxta 100 mg injection is designed to be used in combination with chemotherapy to enhance its effectiveness in treating various metastatic cancers. It works by targeting the blood supply to the tumor, rather than acting as a traditional chemotherapy agent itself. It works by targeting the blood supply to the tumor ,rather than acting as a traditional chemotherapy agent itself.

3. Helps manage advanced cancers

Bryxta 100 mg injection is an anti-cancer medication containing Bevacizumab, which is used to manage various advanced or metastatic cancers. It works as a targeted therapy that inhibits the formation of new blood vessels within tumors, starving them of oxygen and nutrients to slow their growth.

 

Conclusion: Bryxta 100 mg injection is a potent, targeted anti-cancer medication used to treat various advanced or metastatic cancers by inhibiting tumor blood vessel growth. It act as an anti-androgenic agent ,targeting vascular endothelial growth factor (VEGF) .it is used for metastatic colorectal, non-small cell lung, kidney, brain ,cervical ,ovarian, Fallopian tube and liver cancers. It is a prescription drug administered by healthcare professional via IV infusion and is not recommended for children under 18.

 

FREQUENTLY ASKED QUESTIONS(FAQ) :

 

QUESTION: IS Bryxta a chemotherapy drug?

Bryxta is an anti-cancer targeted therapy drug containing

,bevacizumab  designed to inhibit blood vessel formation to starve tumors. While technically an anti-androgenic agent . it is frequently used in combination with chemotherapy to treat various cancers, including lung, colorectal, brain ,kidney and ovarian cancers.

QUESTION: How long does treatment last?

Bryxtra treatment is generally continued for as long as the cancer is controlled and side effects remain manageable. There is no fixed end date, treatment continues as long as it is effective and tolerated. It is commonly used in combination with other chemotherapy drugs.

 

QUESTION: Can Bryxta cure cancer?

No, Bryxta is an anti cancer medication used to treat various types of advanced or metastatic cancer in combination with other therapies. It does not cure cancer. It is typically a part of comprehensive treatment plan and is not a universal cure for the disease. There is currently no universal cure for all types of cancers.

REFRENCES:

1.https://www.apollopharmacy.in/medicine/bryxta-100mg-4ml-inj?srsltid=AfmBOoq2yUd8APYOXgCANk1uLX0XVLTmOrL-HhoE1jix-f8yhPp_8-YX

2.https://www.truemeds.in/medicine/bryxta-100-mg-injection-4-ml-tm-inon2-000960

3.https://www.practo.com/medicine-info/bryxta-100-injection-45724

Posted on:

UNDERSTANDING BORTEZOMIB THERAPY WITH BORVIZ 2 mg

WHAT IS BORVIZ 2 MG?

Borviz 2 MG injection is a chemotherapy medication classified as a protease inhibitor, contains the active ingredient Bortezomib . it is prescribed for the treatment of multiple myeloma,a cancer of plasma cells in the bone marrow ,and mantle cell lymphoma, a less common cancer affecting the lymph nodes. It is an anti neoplastic agent that interferes with the growth of cancer cells ,which are eventually destroyed by the body.

DRUG CLASSIFICATION:

  •  Action class: proteasome inhibitors
  • Therapeutic class : anti-neoplastic /targeted therapy
  •  Chemical class: phenylalanine derivative
  •  Active ingredient: Bortezomib
  •  Usage: use in the treatment of multiple myeloma and mantle cell lymphoma
  •  Administration: intravenous or subcutaneous injection by a healthcare professional.

It is a cytotoxic agent primarily used for managing blood cancers, particularly when stem cell transplantation is not suitable.

WHAT ARE THE MEDICAL USES OF BORVIZ 2 MG INJECTION?

Borviz 2 mg injection contains Bortezomib, a protea some inhibitor used to treat adults with multiple myeloma (bone marrow cancer) and mantle cell lymphoma (a type of blood cancer affecting lymph nodes) . it acts by blocking protein breakdown in cancer cells, forcing them to die ,and is often used in combination therapy.

Some of the medical uses of Borviz 2 mg injection are:

1. Treatment of multiple myeloma

      Borviz 2 mg injection is a targeted cancer therapy used to treat multiple myeloma-a bone marrow cancer-by inhibiting protectorates to induce cancer cell death. It is administered by a healthcare professional ,often in combination with other medicine for both newly diagnosed and previously treated patients.

  •  Indications: used for treating multiple myeloma and mantle cell lymphoma. It is utilized in induction therapy before stem cell transplants for patients who cannot undergo a transplant.
  •  Mechanism of action: As a protease inhibitor, it interferes with the degradation of intercelluar proteins, causing an accumulation that leads to cancer cell death.
  •  Administered: it is given by intravenous (IV) or subcutaneous (under the skin) injection by a doctor.
  • Common side effects : low platelet count, peripheral nephropathy ,nausea, vomiting ,fatigue , constipation and fever.
  •  Precautions: requires monitoring of blood counts and organ function . it is not recommended during pregnancy or breastfeeding.
  • Management : patients are often advised to stay hydrated and avoid driving if they feel dizzy or tired.

2. Treatment of mantle cell lymphoma

 Borviz 2 mg injection is a targeted therapy used to treat mantal cell lymphoma (MCL) ,specifically in patients who have not responded to or have relapsed after other therapies. As a proteasome inhibitor, it destroys cancer cells and is often combined with rituximab and chemotherapy administered by a healthcare professional.

  •  Mechanism: it act as a protoseome inhibitor,interfering with the proteosonmes in cancer cells, which leads to their death and stops further growth.
  • Administration: it is administered either intravenously (in to the vein) or subcutaneously (under the skin) by a qualified healthcare professional.
  • Combination therapy : in MCL treatment, Borviz is often used in combination with other chemotherapy agents and rituximab, particularly for patients not suitable for stem cell transplantation.
  • Common side effects: common side effects include nausea, vomiting, diarrhea, peripheral neuropathy ,constipation etc.
  •  Precautions: it is not recommended during pregnancy or breastfeeding . it may cause dizziness, so caution is advised when driving.

3. Used as a part of combination chemotherapy regime

Borviz 2 mg injection is a protea some inhibitor used in chemotherapy to treat multiple myeloma and mantle cell by inducing cancer cell death. It acts by blocking protein degradation, causing stress that kills malignant cells. It is often used in combination with other agents like dexamethasone or thalidomide.

  • Multiple myeloma: used for treating myeloma, especially in patients who have not received prior treatment and are ineligible for blood stem cell transplantation.
  • Mantle cell lymphoma: used for patients with this type of non-hodgkins lymphoma who have received at least one prior therapy.
  •  Mechanism: as a protesome inhibitor, it breaks down essential protein in cancer cells, forcing them to undergo apoptosis .

WHAT ARE THE BENEFITS OF BORVIZ 2 MG INJECTION?

 

Benefits of Borviz 2 mg injection are:

1. Helps slows the growth of cancer cells

   Borviz 2mg injection, containing the active ingredient Bortezomib, is a protesome inhibitor used to treat multiple myeloma and mantle-cell lymphoma by slowing cancer cell growth and promoting their death. It works by interfering with proteosomes to induce apoptosis in cancer cells. It is primarily used for multiple myeloma and mantle cell lymphoma. As a protosome inhibitor, it interrupts the normal degradation of proteins within cancer cells, causing a toxic buildup that leads to cell death.

2. Improves treatment outcomes in multiple myeloma

       Borviz 2 mg injection ,which contains Bortezomib as its active ingredient, is a highly effective ,FDA approved proteasome inhibitor used to treat multiple myeloma and mantle -cell lymphoma. It significantly improves treatment outcomes by halting the progression of cancer cells, increasing survival rates and inducing deep responses in both newly diagnosed and refectory patients. As a proteasome inhibitor, it disrupts the 26s proteosome in cancer cells, leading to an accumulation of toxic proteins,which causes the cancer cells to undergo apoptosis.

3. May be combined with other cancer medicines for better results

  Borviz 2 mg is frequently combined with other medications like dexamethasone, melphalan, prednisone or rituximab to enhance efficiency . the treatment is administered by a professional ,often resulting in better outcomes than single agent therapy. It is often combined with dexamethasone, or with melphalan and prednisone. It is commonly combined with rituximab and other chemotherapy drugs. They are used with dexamethonase and thalidomide prior to stem cell transplantation.

      CONCLUSION: Bortezomib therapy is a highly effective, standard of care proteasome inhibitor for treating multiple myeloma and mantle cell lymphoma ,significantly improving patient survival rates. Subcutaneous administration is preferred for better tolerabilty, with manageable side effects like peripheral nephropathy and thrombocytopenia making it a cornerstone treatment for both newly diagnosed and relapsed patients.

FREQUENTLY ASKED QUESTIONS(FAQ)

QUESTION: IS BORVIZ A CHEMOTHERAPY DRUG?

Borviz is a targeted chemotherapy injection used to treat multiple myeloma and mantle-cell lymphoma by stopping cancer cell growth. it is important to maintain hydration during treatment and inform doctors of any pre-existing liver, kidney or heart conditions.

QUESTION: HOW MANY TREATMENT CYCLES ARE REQUIRED?

Treatment is administered in cycles, with the number of cycles depending on whether the cancer is newly diagnosed or relapsed. Generally several cycles are recommended, which may be adjusted based on the patient’s response to treatment. Treatment typically involves a series of cycles, often continuing based on clinical response.

QUESTION: CAN IT CURE MULTIPLE MYELOMA?

Borviz is a potentproteasome inhibitor used to treat multiple myeloma by inhibiting the growth of cancer cells, often leading to remission or significantly slowed disease progression. While it is not considered a permanent cure, it is highly effective in

managing newly diagnosed and relapsed cases.

REFRENCES

1.https://health29.in/item/borviz-2mg-injection-lyophilized-borviz%202mg%20injection%20%28lyophilized%29

2.https://www.apothecare.in/products/borviz-2mg-injection

3. https://www.tradeindia.com/products/borviz-2mg-inj-c7933103.html

Posted on:

EVERYTHING YOU NEED TO KNOW ABOUT AZADIN 100ML VIAL


Azadin (Azacitidine ) 100mg injection is a prescription chemotherapy medicine used to treat blood and bone marrow cancers ,specifically myelodysplastic syndromes(MDS) , acute myeloid leukemia (AML) and chronic myelomoocytic leukaemia (CCML) . it acts as an anti neoplastic agent that kills or stops the growth of cancer cells.

HOW IMPORTANT ARE CHEMOTHERAPY AND OTHER Targeted TREATMENTS IN BLOOD CANCER?
Chemotherapy and targeted treatments are cornerstone therapies for blood cancers (leukemia, lymphoma,myeloma) designed to systematically eliminate rapidly dividing cancer cells throughout the body, often achieving remission rates. While chemotherapy acts broadly to kill cancer cells, targeted therapies focus on specific genetic mutations or proteins, offering more precise treatment with fewer side effects and quality of life.

Importance of chemotherapy in blood cancer
l Systematic treatment : Because blood cancer are not localized to one organ, chemotherapy travels through the blood stream to reach cancer cells everywhere, especially in the bone marrow.
l High cure/control rates: it is highly effective in destroying abnormal cells, enabling long-term remission

.
2.Combination therapy : it is often paired with radiation ,stem cell transplant or targeted agents to boost efficacy.
l Phased approach: chemotherapy is delivered in cycles : induction(rapidly killing cells to achieve remission) , consolidation (eliminating remaining cells ) and maintenance (preventing recurrence)

Importance of targeted treatment in blood cancer
l Precision and specificity:These drugs target specific genetic mutations, proteins or pathways that cause cancer cells to grow and survive,sparing mostly healthy cells.
l Reduced side effects: By focusing on cancer cell weakness, they often cause less damage to healthy tissues compared to conventional chemotherapy.
2. improved forebeareance consequence: Targeted therapies can efficausly treat cancer that can relapsed or become resistant to traditional chemotherapy.
Both treatments are essential to the modern, personalized management of blood cancers, often used in tandem to maximize survival chances.

WHAT IS AZADIN 100 MG?
azadin 100 mg injection is a prescription cancer medication containing Azacitidine, used to treat myelodysplastic syndromes (MDS) ,acute myeloid leukaemia (AML) and chronic myleomonocytic leukaemia (CMML) . it works by killing or inhibiting the growth of abnormal blood/one marrow cells and is typically administered by a healthcare professional.
Key details:
l Indication: treats specific blood and bone marrow cancers
l Administration: given by subcutaneous injection or intravenous infusion.
l Storage: requires refrigeration
l Mechanism: a nucleoside metabolic inhibitor that acts as a chemotherapy agent.
This medication is often used when patient is not eligible for a stem cell transplantation. It is essential to consult a doctor ,as it is a potent, toxic and highly specalized chemotherapy drug.

WHAT ARE THE MEDICAL USES OF AZADIN 100 MG VIAL?
Azadin 100mg vial is an anti neoplastic (anti cancer) chemotherapy medication used to treat blood disorders and cancers, specifically myelodysplastic syndromes (MDS) ,chronic myleodyplastic leukemia (CMML) and acute myleiod leukemia (AML). it works by killing or stopping the growth of abnormal cancer cells in bone marrow.

Following are the medical uses of azadin 100 mg vial are :

1. Treatment of Myelodysplastic syndrome (MDS)
Aazidin is an anti-metabolic medication used in the treatment of myelodysplastic syndromes (MDS), including immediate -2 and high-risk cases, as well as chronic myelomonocytic leukemia (CMML) and acute myeloid leukaemia (AML) . it wors by inhibiting cancer cell growth and promoting normal blood cell production in the bone marrow.
l Administration: it is administered by a healthcare professional ,usually via subcutaneous injection or intravenous infusion.
l Treatment approach: treatment involves specific cycles, where the frequency and duration are determined by an oncologist based on patient responses and tolreabilty.
l Common side effect: these include nausea, vomiting ,injection site reactions, fever ,constipation ,diarrhea and cytopennias
l Monitoring: Regular blood test are required to monitor blood counts, liver and kidney functions.
l Precautions: patients should avoid alcohol, stay hydrated and report any severe side effects such as persistent infections or bleeding.

2. Treatment of acute myeloid lukemia (AML) in certain patients
Azadin (containing the active ingredient Azacitidine ) is a chemotherapy medication used for the treatment of certain adults with Acute myeloid leukemia (AML) who are not candidates for intensive chemotherapy or homeopathic stem cell transplantation. It is particularly indicated for patients with 20-30% blasts and multi-lineage dysplasia.
l Indications: specifically approved for AML high-intensity curative treatments. It is also used for meylodysplastic syndrome (MDS) and chronic meylomonocytic leukaemia(CMML).
l Mechanism of action: As a hypomethylating agents, it works by inhibiting DNA methyltransferase ,which helps reactivate tumor-suppressor genes and stops the growth of cancer cells.
l Administration: it is administered by a healthcare professional, usually via subcutaneous injection into the thigh, abdomen, or upper arm.
l Common side effect:
1. Hematological: low white blood cell count (neutropenia) ,low platelet count (thrombocytopenia), and low red blood cell count (anemia).
2. Gastrointestinal: Nausea, vomiting, diarrhea, and constipation.
3. Other: injection site reactions (pain,redness) ,fever, fatigue and dizziness.
Treatment with Azadin should only be initiated and monitored under the supervision of a qualified physician experienced in the use of chemotherapeutic agents.

3 Managing bone marrow disorders
Azadin is a crucial medication in the management of specific, high-risk bone marrow disorders. It works as a hypomethylating agent that helps restore normal blood cell production and induces the death of abnormal cancer cells in the marrow.
l Indication: it is approved for myelodysplastic syndrome( MDS) ,chronic myelomonocytic leukemia (CMML) , and Acute Myeloid Leukemia (AML) .

l Administration: it is administered via subcutaneous injections or intravenous infusion, typically on a 7-day cycle every 4 weeks . an oral form (ONUREG) is used for continued remission in AML .
l Efficacy: studies have shown it improves overall survival and can delay disease progression in higher -risk MDS patients compared to conventional care.
l Mechanism of action: it is a pyrimidine nucleoside analog that ,when incorporated into DNA, inhibits DNA methyltransferase,allowing for the potential reactivation of genes that regulate differentiation and maturation of hematopoietic cells.
It is important to receive regular monitoring for infections and blood counts, and for healthcare providers to manage the potential for severe myelosuppression.

Conclusion: Azadin 100mg injection (containing Azacitidine ) is an anti neoplastic medication primary used to treat adults with blood and bone marrow disorders ,specifically Myelodysplastic leukemia (CMML) and acute myloid leukemia (AML) .it is a crucial, high-potency and often life-saving therapeutic option for patients ineligible for stem cell transplant ,working by inhibiting DNA methyltransferase to induce cell death in cancerous cell and promote normal blood cell production.

FREQUENTLY ASKED QUESTIONS (FAQ):
QUESTION: HOW LONG DOES AZADIN TREATMENT LAST?
Azadin treatment is typically administered in 28 -day cycles, with the medication taken for 7 consecutive days or 14 days within each cycle.

QUESTION: IS AZADIN A CHEMOTHERAPY DRUG?
Yes, Azadin is a prescription chemotherapy drug used in the treatment of specific blood and bone marrow cancers. It is classified as anti metabolite, which at as a hypomethylating agent to stop cancer cells from growing.

QUESTION: CAN AZADIN CURE BLOOD CANCER?
Azadin is a chemotherapy medication used to treat certain types of blood and bone marrow cancers, but it is not considered a universal cure for all blood cancers. It is a potent drug that works by interfering with the growth of cancer cells, which kills them off and allows normal blood cells to grow.

QUESTION: WHAT PRECAUTIONS SHOULD Patients FOLLOW DURING TREATMENT?
l It must be administered under the supervision of a healthcare professional, usually via subcutaneous injection or intravenous infusion
l The drug can be significantly lower white blood counts ,increasing the risk of infections. Avoid crowd places and people who are sick.
l This medication can cause serious birth defects. It is contraindicated during pregnancy and breastfeeding.
l Inform your doctor if you have existing liver or kidney disease, as dose adjustment may be necessary.

REFRENCES:

1.https://www.netmeds.com/product/azadine-100mg-injection-1-s-lui7y3-8352685

2.https://macariushealth.com/products/oncology-cancer-care/azadine-100mg-injection-100mg/

3.https://www.practo.com/medicine-info/azadine-100-mg-injection

4.https://www.medkart.in/order-medicine/azadine-injection?srsltid=AfmBOoo6tJ_bc1hHqKtQUAx64ROgG23wu_WC7J-tX6hqyn0mPxytqduB


 Read more “EVERYTHING YOU NEED TO KNOW ABOUT AZADIN 100ML VIAL”

Posted on:

EVERYTHING YOU NEED TO KNOW ABOUT ARPIMUNE 25MG 5’S

Arpimune ME 25 mg capsule is an immunosuppressent medication containing cyclosporine, used to prevent organ rejection in kidney, liver and heart transplant recipient. It works by suppressing the immune system to stop it from attacking the new organ. It is also used for severe rheumatoid arthritis, psoriasis and nephrotic syndrome. It is a prescription based medicine and should b taken under strictly medical supervision.

Immunosupressant medication are essential ,often life-saving drugs that suppress a hyperactive immune systems to prevent the rejection of transplanted organs and treat severe autoimmune diseases. By inhibiting immune response, they stop body from attacking healthy tissues or foreign organs, requiring strict, life-long adherence to maintain long-term health.

 

WHAT IS CYCLOSPORINE?

 

Cyclosporine is a powerful immunosuppressant medicine used primarily to prevent organ rejection in kidney ,liver and heart transplant. It works by suppressing the immune system’s T-cells to prevent them from attacking transplanted organ or tissues. In other words, cyclosporine is an immuno suppression that inhibits T cells activation by binding to the protein cyclophilin, forming a complex that inhibits the phosphate calcineurin . this blockage prevents the dephosphorylation and nuclear translocation of NF-AT (nuclear factor of activated T cells ),inhibiting interleukin-2 production and T-lymphocyte proliferation.

It is used to prevent organ rejection and treat various autoimmune diseases, including rheumatoid arthritis and psoriasis, due to its ability to suppress cell mediated immune reactions.

Mechanism of action :

l Target: primarily inhibits T-helper cells, although it also impacts T-suppressor cells and reduces interleukin production.

IL-4

l Pathway blockage: cyclosporine binds to cyclophilin- complex inhibits calcineurium -NF-AT activation is blocked _IL-2 gene transcription is needed.

l Cell cycle impact: specifically inhibits immunocomponent lymphocytes during the G0 and G1 -phase.

l Specificity: it is highly specific, allowing for immune suppression without general bone marrow suppression .

l Other actions: Acts as a inhibitor of cytochrome p450 3A4 and p-glycoprotein.

 

WHAT ARE THE USES OF ARPIMUNE ME 25 MG?

Arpimuine 25 mg capsule, containing cyclosporine ,is an immunosuppression used primarily to prevent organ rejection (kidney, liver, heart ) in transplant patients. It is also prescribed for several autoimmune conditions, including arthritis, psoriasis and atopic dermatitis.

Some of the uses of Arpimune ME 25 mg are:

1. Prevention of organ transplant rejection (kidney, liver,heart)

Arpimune ME 25 mg capsule, containing cyclosporine ,is an immunosuppresant used to prevent the rejection of transplanted organs (kidney, liver, heart ) and bone marrow/stem cell. It works by suppressing the immune system to stop the body from attacking the new organ. It is effective in preventing graft-host disease( GVHD) in bone marrow or stem cells transplant.

2. Treatment of autoimmune disorders

Arpimune ME 25 mg capsule contains cyclosporine, an immunosuppresent used to severe autoimmune conditions by inhibiting T-cells activity ,reducing inflammation ,and slowing tissue damage . it is used to treat severe psoriasis, rheumatoid arthritis ,atopic dermatitis and nephrotic syndrome, often in patients who have not respond to other treatments. It works by suppressing the immune system to prevent it from attacking the body own tissues. It can increase the risk of skin cancer ,infections and high blood pressure. Regular blood test are necessary to monitor kidney function, blood pressure and drug level.

 

3. Severe Rheumatoid arthritis

Arpimune ME 25 mg is an immunosuppressant used to treat severe, active rheumatoid arthritis in adults when other treatments such as methotrexate have failed. It suppresses overactive immune responses to reduce joint pain ,swelling and stiffness ,thereby limiting joint damage.

 

4. Severe psoriasis

Arpimune ME 25 is used to treat severe, plaque -type psoriasis that has not responded to other systematic treatments. It act as an immumosuppresant to reduce rapid skin cell turnover ,inflammation and red ,scaly patches. It is generally used for short-term ,episodic treatment. It suppresses the immune system to reduce skin inflammation and rapid cell growth. It requires frequent monitoring of kidney function, liver function and blood pressure ,as it may cause damage to these organs or raise blood pressure.

 

WHAT ARE THE BENEFITS OF CONSUMING ARPIMUNE ME 25 MG?

 

Some of the benefits of consuming Arpimune ME 25 MG are :

1. Prevents immune system from attacking transplanted organs

Arpimune 25 suppress the immune system T-cells to prevent them from recognizing the transplanted organ as a foreign body ,thus protecting it.because it suppress the immune system, it lowers the body’s ability to fight infections.

 

2. Helps control autoimmune disease

Arpimune ME 25 mg contains cyclosporine,an immunosuppression used to control severe autoimmune disease by inhibiting t-lymphocytes activity and reducing immune-mediated inflammation. It controls the immune system to reduce rapid skin cell growth, resulting in clearer skin and reduced rash, redness and pain.

 

3. Reduces inflammation and immune activity

Arpimune ME 25 mg is used to control severe autoimmune diseases by inhibiting T-lymphocytes activity and reducing immune-mediated inflammation. It is used when other therapies fail to treat conditions like severe rehumoind arthritis ,psoriasis ,atopic dermatitis and nephrotic syndrome. It controls the immune system to reduce rapid skin cell growth ,resulting in clearer skin and reduced rash ,redness and pain.

 

WHAT ARE THE POSSIBLE SIDE EFFECTS OF CONSUMING ARPIMUNE 25 MG?

Some of the possible side effects of consuming Arpimune 25 mg are:

1. High blood pressure

Arpimune 25 mg can cause high blood pressure as a common side effect. It act as an immunosuppressant that can increase blood pressure ,worsen existing hypertension . regular monitoring of blood pressure is essential while taking this medication. If one can experience high blood pressure, report it to your doctor,as they may adjust your dose.

2. Kidney function changes

Arpimune 25 mg is known to cause kidney function changes and can potentially lead to kidney damage. It is a potent immunosuppresant that requires careful monitoring of kidney health. A common side effect is alternated kidney function, including potential kidney damage, which may manifest as reduced urine output.

 

3. Tremors or headache

Armipune ME 25 mg is known to cause tremors and headache as a common side effect. These neurological symptoms, along with others like numbness or tingling , are well -documented reactions to this improvement medication.

 

CONCLUSION: Arpimune 25 mg capsules, containing cyclosporine ,are vital immunosupressant used to prevent organ rejections in transplants (kidney, liver ,heart) and treat severe autoimmune diseases like psoriasis and rehumoind arthritis by calming the immune system. It requires strict, consistent medical supervision due to side effects like hypertension and increased infection risk.

 

FREQUENTLY ASKED QUESTIONS

QUESTION: HOW LONG SHOULD ARPIMUNE 25 MG BE TAKEN?

Arpimune 25 mg should be taken exactly as prescribed by healthcare provider . it is often a long-term ,sometimes lifelong ,medication for transplant rejection prevention, while treatment for conditions like severe psoriasis or rhemunonind arthritis is determined by managing physician.

 

QUESTION: CAN IT WEAKEN IMMUNE SYSTEM?

Arpimune 25mg is an immunosuppressant that reduces immune system activity to prevent transplant rejections and treat autoimmune conditions like severe posaris or rhemunonind arthritis. It works by inhibiting T-cells , which increases the risk of infections ,high blood pressure and skin cancer.

 

QUESTION: IS REGULAR BLOOD MONITORING REQUIRED?

Yes, armipune 25mg requires regular, periodic blood monitoring to manage its narrow therapeutic index and prevent potential side effects.

 

QUESTION: CAN ARMIPUNE 25 MG STOPPED SUDDENLY?

No, you should never suddenly stop taking Armipune 25 mg without consulting your doctor. Abruptly stopping this medication can cause serious health consequences including a high risk of organ rejection in transplant patients or the severe worsening of autoimmune conditions like psoriasis or rheumatoid arthritis.

REFRENCES:

1.https://www.lybrate.com/medicine/arpimune-me-25mg-capsule

2.https://www.medkart.in/order-medicine/arpimune-me-25mg-capsule-5s?srsltid=AfmBOoqW8b3svrY19Tz2bP2o-Cvh-hsGwBZoqtbqdIsxpX49SSpjeYLG

3.https://m.indiamart.com/proddetail/arpimune-me-25-mg-capsules-2857272388491.html

 

Posted on:

COMPREHENSIVE GUIDE TO ALTRAZ 1MG TABLETS


Altraz 1 mg is an anticancer drug with the ingredient Anastrozole . it belongs to the medication class known as aromatase inhibitors. It is used to treat hormone dependent breast cancer in postmenopausal woman. It is used to treat early breast cancer in the post menopausal women . it is used as a first line treatment for breast cancer that has spread within the breast or to other parts of the body in women who have attained menopause. Altraz 1mg tablet works by lowering the level of estragon in the body.
Altraz 1mg tablet, contains Anastrozole, is an essential hormone therapy for treating hormone receptor-positive breast cancer in postmenopausal women. As an aromatase inhibitor, it reduces estrogen levels ,thereby slowing or stopping growth of cancer cells . it is used for early or advanced breast cancer.

WHAT IS ALTRAZ?


Altraz (active ingredient Anastrozole ) is classified as an aromatic inhibitor and an anti-cancer hormone therapy, which is primarily used to treat hormone receptor-positive cancer in postmenopausal women by significantly reducing estrogen levels in the body ,which slows or stops tumour growth.
KEY CLASSIFICATION:
DRUG CLASS : non-steroidal Aromatase inhibitor (AI)
THERAPEUTIC CATEGORY: Anti neoplastic (anti-cancer )agent .
MECHANISM OF ACTION: it works by blocking the enzyme aromatase, which reduces the peripheral conversion of androgen into estrogen.
PRIMARY USE: treatment of post menopausal women with hormone dependent (estrogen receptor positive ) breast cancer.
ADMINISTRATION: oral tablet.

WHAT IS THE ROLE OF ALTRAZ IN LOWERING HORMONE RECEPTOR POSITIVE BREAST CANCER?
Altraz (active ingredient Anastrozole ) is an aromatase inhibitor used to treat hormone receptor -positive (HR) breast cancer in postmenopausal women. It reduces estrogen levels by blocking the aromatase enzyme, which stops the growth of tumours that rely on estrogen. It is commonly used as an adjuvant therapy to prevent cancer recurrence.
Lowering estrogen levels is a primary, effective treatment for hormone receptor-positive breast cancer ,as these cancer rely on estrogen to grow. Hormone therapies such as aromatase inhibitors and ovarian suppression ,are used to starve cancer cells of this hormone ,reducing recurrence risk in postmenopausal patients. These treatments are specifically for tumours that test positive for estrogen or progesterone receptors. Often these therapies are used in combination with surgery, radiation or chemotherapy ,following them to manage the cancer long treatment.

WHAT ARE THE USES OF ALTRAZ 1 MG TABLET?


USES OF ALTRAZ 1MG TABLET ARE :


1. TREATMENT OF HORMONE RECEPTOR -POSITIVE BREAST CANCER IN POSTMENOPAUSAL WOMEN
Altraz 1mg is a third-generation, once-daily, aromatase inhibitor (AI) used to treat hormone receptor positive early and advanced breast cancer in postmenopausal women. It works by blocking estrogen production ,reducing recurrence risk more effectively than tamoxifen in many cases, often prescribed for 5 years as adjuvant therapy. Clinical trails have shown that Altraz is superior or equivalent to tamoxifen in improving disease -free survival in postmenopausal patients. The standard dose is 1 mg tablet taken orally once daily.


2. EARLY -STAGE BREAST CANCER (ADJUVANT THERAPY)
Altraz 1mg is an aromatase inhibitor used specifically for postmenopausal women to treat hormone receptor-positive early-stage breast cancer. It is highly effective in reducing the risk of cancer recurrence after initial treatment ,such as surgery or radiation. It works by blocking the aromatase enzyme, which is responsible for converting other hormones into estrogen in the body’s fatty tissues. By significantly lowering estrogen levels, it slows or stops the growth of hormone-sensitive tumours. It is not recommended for postmenopausal women . the standard dose is 1 mg once daily.


3. ADVANCED OR METASTATIC BREAST CANCER

Altraz 1mg is used to treat early stage hormone receptor -positive breast cancer in postmenopausal women, often for 5 years to reduce recurrence risk. It is used as a first line treatment for hormone receptor positive or unknown locally advanced or metastatic breast cancer. As a aromatase inhibitor, it blocks the conversion of androgen to estrogen, thereby depriving cancer cells of the hormone they need to grow. It has shown superior efficacy and tolerably compared to tamoxifen in postmenopausal women with early-stage disease.

WHAT ARE THE BENEFITS OF TAKING ALTRAZ 1MG TABLET?

Some of the benefits of consuming ALTRAZ 1MG tablet are:


1. REDUCES RISK OF CANCER RECURRENCE


Altraz 1mg (Anastrozole ) is used to reduce the risk of cancer recurrence in postmenopausal women with hormone receptor-positive (HR)early breast cancer. It is commonly prescribed as an adjuvant therapy to prevent the cancer from returning. As a aromatase inhibitor, it lowers estrogen levels in the body, which slows or stops the growth of estrogen depending cancer cells. The standard dose is 1 mg taken orally once daily. It is often prescribed for 5 years or longer.

 

2.SLOWS TUMOR GROWTH 


Altraz 1mg is an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women by significantly reducing estrogen levels. By lowering estrogen, which fuels tumour growth, it effectively slows or stops the progression of cancer cells. It primarily treats hormone dependent breast cancer in postmenopausal women. It also inhibits the aromatase enzyme, which reduces estrogen production in the body. It also helps prevent cancer recurrence after surgery and controls the spread of advanced cancer. Standard dose is once daily ,with or without food.

3. IMPROVES DISEASE -FREE SURVIVAL


Altraz 1mg is clinically proven to improve disease-free survival for postmenopausal women with hormone receptor-positive early breast cancer. It works as an aromatase inhibitor ,which reduces estrogen levels ,thereby slowing or stopping the growth of cancer cells. Studies ,including the 100-month analysis of the ATAC trail, have shown that 5 years of Anastrozole treatment improves disease -free survival compared to other treatments.

CONCLUSION: Altraz 1 mg tablet, containing Anastrozole ,is an effective, once-daily aromatase inhibitor used to treat hormone-dependent breast cancer in postmenopausal women. It works by importantly reducing estrogen levels to slow tumor growth. Key considerations include managing common side effects like joint pain, flashes and reduced bone density.

FREQUENTLY ASKED QUESTIONS (FAQ):
QUESTION: HOW LONG SHOULD ALTRAZ 1 MG BE TAKEN?
Anastrozole (Altraz) is typically prescribed to be taken to treat or reduce the risk of postmenopausal hormone receptor-positive breast cancer . it should be taken exactly as prescribed ,at the same time each day, and continued as long as advised by an oncologist to prevent cancer recurrence.

QUESTION: DOES ALTRAZ CAUSE HAIR LOSS
Yes Altraz (Anastrozole) can cause hair loss or side effect effecting up to a quarter of users. It typically causes mild to moderate thinning rather than complete baldness. This is caused by lower estrogen levels, and effect is generally not permanent, with potential for reversal after treatment.

QUESTION: CAN ALTRAZ BETAKEN WITH OTHER CANCER MEDICINES?
Altraz (Anastrozole) should generally not be taken with tamoxifen or other estrogen -containing medications, as they can significantly reduce its effectiveness.
Also Read:

1.https://www.1mg.com/drugs/altraz-tablet-45485?srsltid=AfmBOoqqlF5T-ALcxJsxa0mTZsncznJxeSDgMO_jN16aqcZ8512ci9q_&wpsrc=Google+Organic+Search

2.https://www.apothecare.in/products/altraz-1mg-tablet

3. https://www.practo.com/medicine-info/altraz-1-mg-tablet-37231

4. https://www.truemeds.in/medicine/altraz-1-mg-tablet-14-tm-tacr1-001714

 

Posted on:

WHY INFLUVAC VACCINATION IS IMPORTANT FOR FLU PREVENTION?

à

 

Posted on:

PNEUMONOVAX 23 PFS:WHO SHOULD GET IT AND WHY IT MATTERS

  1. Whys

 

Pneumonovax 23 is a vaccine designed to prevent pneumococcal infections, such as pneumonia, meningitis, and bacteremia, caused by 23 different strains of streptococcus pneumonia bacteria. This PFS(pre-filled syringe) is a convenient, sterile ,ready to use liquid format for administration.

Pneumonovax 23 is a vital vaccine that protects against 23 strains of streptococcus pneumonia bacteria, which cause severe,sometimes fatal infections like pneumonia, meningitis, and bloodstream infections. It is critical for adults 65 plus ,smokers ,and individuals with chronic hospitalization and severe infections.

 

HOW IMPORTANT DOES PNEUMNOVAX 23 PFS VACCINE FOR ADULTS?

Pneumonovax 23 (PPSV23) is a crucial vaccine for adults aged 50 plus and those with high -risk conditions, protecting against 23 types of pneumonia causing bacteria. It significantly reduces the risk of invasive pneumococcal disease and pneumonia ,lowering hospitalization and morality ,particularly in older adults and individuals with degenerative illness.

 

Target group: recommended for adults 65 plus ,adults 19-64 with chronic conditions (e.g asthma, COPD,diabetes, heart disease) ,smokers and immune compromised individuals.

Protection: covers 23 common streptococcus pneumonia e stereotypes responsible for over 90% of invasive disease.

Administration: typically a single intramuscular injection ,with a booster sometimes recommended after 5 years for high-risk individuals

Effectiveness: studies indicate an overall efficacy of 60-70% in preventing invasive disease.

Side effects: common reactions include soreness at the injection site, fever or rash.

 

WHAT IS PNEUMNOVAX 23?

Pneumococcal polysachride  vaccine, sold under the brand name pneumnovax 23 ,is a pneumnococal vaccine that is used for the prevention of pneumococcal disease caused by the 23 stereotype of streptococcus pneumoniae contained in the vaccine as capsular polysachrides.  The polysachrides agents were added to induce type-specific antibodies that enhance phagocytes and killing of streptococcus pneumonia e bacteria by phagocyte immune cells.

Pneumovax 23 is manufactured by Merck sharp &Dohme corp..,a subsidiary of Merck &co ,inc . it is a vaccine designed to protect against infections caused by streptococcus  pneumoniae bacteria , including pneumonia and meningitis. The product is often distributed as a pre -filled syringe .

Key manufacture & Information

Manufacturer: Merck Sharp & Dohme corp. 

Alternative name: Merck Sharp & Dhome BV (often used in international contexts) .

Manufacturing site: west point ,Pennsylvania,USA

Distributor/Marketer :  MSD pharmaceuticals pvt ltd. (india)

Format: As of April 2023, the manufacturer supplies PNUMOVAX 23 primarily as a 10-pack of pre -filled single-dose Luer -lok syringes.

The vaccine is indicated for individuals 2 years of age and older, with a focus on adults 50 and older or those with high risk conditions.

 

WHAT DISEASES DOES PNEUMONOVAX 23 PREVENT?

Diseases that are prevented by PNEMONOVAX 23 are :

PNEUMONOCOCAL PNEUMONIA

Pneumnovax 23 (PPSV23) helps prevent pneumococcal pneumonia and other serious infections caused by 23 common strains of streptococcus pneumonia bacteria.it is highly recommended by adults up to 65 age, individuals aged 2 plus with high -risk conditions and smokers. It protects against 23 strains of bacteria, reducing the risk of severe disease and hospitalization. it is effective at preventing pneumococcal pneumonia, particularly in reducing morality for high-risk individuals and nursing home residents.

 

BACTEREMIA (BLOODSTREAM INFECTION) 

Pneumococcal vaccines (PCV13, PPSV23) are highly pneumococcal disease, including bacteremia, (bloodstream infection ) and pneumococcal pneumonia ,by inducing antibodies that target specific stereotypes of streptococcus pneumoniae.  Studies shown that vaccines can be 78.5% effective in preventing type-specific pneumococcal pneumonia and bacteremia.  It works by stimulating antibodies that block the bacteria from invading the blood or causing pneumonia.

MENINGITIS

Pneumonia l cocal vaccines (PCV13, PCV15, PCV20 and PCV23) are the primary, highly effective method to prevent both pneumococcal meningitis and pneumococcal pneumonia. These vaccines protect against various strains of streptococcus pneumonia  bacteria that can cause both invasive diseases . these vaccines target the most common harmful strain . since the year  2000 , these vaccines have saved over 1.6 million lives and significantly reduce the incidence of morality  from pneumococcal disease.

 

OTHER INVASIVE PNEUMOCOCCAL DISEASES

Invasive pneumococcal diseases (IPD) including bacteria , septicemia and meningitis- are severe infections caused by streptococcus pneumonia that are effectively prevented by pneumococcal conjugate vaccines (PCV13, PCV15, PCV20) and the polysachride vaccine (PPSV23) ,which also protect against pneumococcal pneumonia .it reduces the overall burden of disease.

 

HOW IS PNEUMNOVAX 23 ADMINISTERED?

Pneumnovax works by each integrating the immune system to produce antibodies against 23 common types of streptococcus pneumoniae bacteria, protecting against invasive diseases like pneumonia and meningitis. It is a  polysachride vaccine that uses purified sugar coatings from the bacteria to trigger an immune response without causing disease.

Pneumnovax 23 administrated by the following ways:

STIMULATE  IMMUNE RESPONSE

Pneumonovx 23 (PPSV23) stimulate the immune response by exposing it to 23 different purified capsular polysaccharide antigens from the most common and invasive streptococcus pneumonia  bacteria. It is designed to trigger a T-cell-independent immune response .primarily in adults aged 50 and other high risk individuals.

 

PRODUCTION  OF PROTECTIVE ANTIBODIES

Pneumonovax 23 (PPSV23) is a 23- variant pneumococcal polysachride vaccine designed to induce type-specific antibodies that heighten optimization ,phagocytes . proactive antibody levels generally develop within 2 to 3 weeks after vaccination. More than 80% of healthy adults develop antibodies against the stereotype in the vaccine . studies show a 5.4 -fold average increase in antibody levels across different stereotypes.  The vaccine is 60% to 70% effective in preventing invasive pneumococcal disease (IPD) in healthy adults.

 

WHAT ARE THE  POSSIBLE SIDE EFFECTS OF PNEUMNOVAX 23 ?

Pneumounovax 23 commonly causes mild, short term side effects ,primarily injection site reactions  like pain, swelling and redness , which may occur in over 75% of patients . other common side effects include headache, fatigue ,muscle pain ,fever and reduced appetite ,generally resolving within 1-2 days.

 

Common side effects:

Injection site reactions: pain/soreness /tenderness (60%-70%) ,swelling/induration (20%-40%) and redness (16%-35%)

Systematic reactions: headache (17%-18%),fatigue /asthenia(13%-18%)

General:  fever (less than 10%)

 

Less common side effects

Local: intense swelling,  ‘’cellulitis-like’’ reactions or hard lumps at the injection site.

Systematic: chills, joint pain ,nausea ,vomiting or rash

Rare :severe allergic reactions or in very cases, Guillain- Barre syndrome.

 

CONCLUSION: pneumonovax 23 (PPSV23) is a highly effective ,safe vaccine for preventing invasive pneumococcal disease (IPD) caused by 23 stereotypes in adults >65 and high-risk individuals . it offers moderate protection against pneumonia and reduces hospitalization ,though its effectiveness may decrease with age and it is not recommended for children under 2.

 

FREQUENTLY ASKED QUESTIONS: 

QUESTION:  HOW LONG DOES PNEUMONOVAX 23  PROTECTION LAST?

Pneumnovax 23 typically provides protection for about 4 to 7 years in adults with antibody levels decline afterward . while some protection may last longer, a booster is often recommended every 5 years for high-risk individuals. Protection begins 2 to 3 weeks after vaccination .

QUESTION: CAN PNEUMNOVAX 23 PREVENT VIRAL PNEUMONIA?

Pneumnovax does not directly prevent viral pneumonia .it specifically protects against 23 types of bacteria that cause bacterial pneumonia, meningitis and bloodstream infections. It is primarily used for adults 65 plus and high -risk individuals . however it can prevent secondary bacterial infections that often occur after a viral infection.

QUESTION: CAN PNEUMNOVAX 23 IS MANDATORY FOR ELDERLY INDIVIDUALS ?

Pneumnovax 23 is strongly recommended for all adults aged 65 years and older by major health organizations , including centre for disease control and prevention (CDC) . it is consider a crucial preventive health measure for elderly people to protect severe infections caused by streptococcus pneumococci bacteria , such as pneumonia, meningitis and bloodstream infections.

REFRENCES

1. https://www.nhs.uk/vaccinations/pneumococcal-vaccine/

2.https://www.apollopharmacy.in/medicine/pneumovax-vaccines-23-0-5ml?srsltid=AfmBOopP0KfiHXcID6lvvhdwPqAeeOvCAqlEGq4Lcdksx4_yOqO-HWIU

3.https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html

4.https://www.news-medical.net/drugs/Pneumovax-23.aspx

 

 

 

 

 

Posted on:

UNDERSTANDING ABIRAPRO 250 MG FOR PROSTATE CANCER TREATMENT

LIVING WITH PROSTATE CANCER: TREATMENT ,DIET& lifestyle TIPS UNDERSTANDING 250 mg for Prostate Cancer Treatment Abirapro 250 mg for Prostate Cancer Treatment

Abirapro 250 mg (Abiraterone(Abiraterone Acetate 250 mg) is a hormonal cancer medication. It is used to treat advanced prostate cancer in men. It works by reducing testosterone levels, which helps stop or slow tumor growth. It is often taken with steroids to manage side effects, usually on an empty stomach.

Abiraterone acetate is a critical component of hormonal therapy used in the management of advanced prostate cancer. It acts as an androgen biosynthesis inhibitor, which reduces the production of testosterone.

WHAT IS ABIRAPRO 250 MG?

Abirapro 250 mg tablet contains Abiraterone acetate, an androgen biosynthesis inhibitor used to treat metastatic castration-resistant prostate cancer. It acts as an anti-neoplastic agent that reduces testosterone production, slowing cancer growth.

DRUG CLASSIFICATION

ACTIVE INGREDIENT: Abiraterone Acetate (250 mg)

DRUG CLASS: Androgen biosynthesis inhibitor, anti-androgen.

ACTION: Abiraterone Acetate inhibits the enzyme CYP17. This enzyme is responsible for producing testosterone in the testis and adrenal glands. By inhibiting it, the progression of prostate cancer is halted.

USAGE: usually taken in combination with prednisone to manage side effects like hypertension and low potassium.

PRESCRIPTION-BASED ANTI-CANCER MEDICATION

Abiraterone acetate, also known as abirapro, zytiga, and others, is a prescription-based oral medication. It is used to treat prostate cancer. This drug works by inhibiting the enzyme CYP17, which reduces the derivation of androgen. This process fuels the growth of prostate cancer cells.

PRESCRIPTION AND USAGE

Medical supervision: This medication requires a valid prescription from an oncologist.

Dosage form: Oral tablets are available.

Administration: It must be taken on an empty stomach.

WHAT ARE THE USES OF ABIRAPRO 250 MG?

Uses of Abirapro 250 mg are:

1. Abirapro 250 mg is used to treat newly diagnosed high-risk metastatic hormone-sensitive prostate cancer in adult men. It is used in combination with androgen deprivation therapy (ADT).

2. The treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. These men are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy. Chemotherapy is not yet clinically indicated for them.

3. The treatment of mCRPC in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

4. Management of metastatic high-risk castration-sensitive prostate cancer (CPC) with prednisone.

5. Treatment of newly diagnosed patients. It is often in combination with prednisone and androgen deprivation therapy.

One must adhere to their doctor’s prescription exactly when taking this medication. They should stick with the recommended dose and follow the length of time advised.

HOW DOES ABIRAPRO 250 MG WORK?

Abirapro 250 mg treats prostate cancer by inhibiting the CYP17 enzyme, which is responsible for the body to produce androgen. It reduces testosterone levels throughout the body, including the testes. This reduction also affects the adrenal glands and tumor tissues. It starves the cancer cells of the hormone they need to grow. As a result, the progression of the cancer slows down.

MECHANISM OF ACTION

Targeted enzyme inhibitors: Abirapro blocks the CYP17 enzyme, which is essential for androgen biosynthesis

Lowering fuel for cancer: it reduces testosterone levels significantly, which helps to stop or slow down the growth of prostate cancer cells.

Precautions: It can cause serious side effects, including liver issues, high blood pressure, fluid retention, and potassium loss.

WHAT ARE THE BENEFITS OF 250 ABIRAPRO 250 MG?

BENEFITS OF ABIRAPRO 250 MG:

HELPS SLOW CANCER PROGRESSION

Abirapro 250 mg is used as a long-term adjunct therapy. It inhibits the growth of cancer cells. This use reduces the risk of cancer coming back after surgery or radiation. It is considered a first-line treatment for early-stage hormone receptor-positive breast cancer. It also slows or stops the growth of tumors that have spread.

IMPROVES SURVIVAL RATE IN ADVANCED PROSTATE CANCER

Abirapro 250 mg is a targeted hormone therapy medication. It is used to treat advanced prostate cancer. This is achieved by inhibiting androgen production, which fuels tumor growth. It is used for:

1. Metastatic castration-resistant prostate cancer (mCRPC): for patients whose cancer has progressed despite traditional hormonal therapy or chemotherapy.

2. For newly diagnosed patients with metastatic high-risk castration-sensitive prostate cancer. They often receive combination treatment with androgen deprivation therapy (ADT) and prednisolone.

CONVENTIONAL ORAL THERAPY COMPARED TO SOME INJECTABLE TREATMENTS

Abirapro 250mg offers a convenient, non-invasive oral alternative to injectable androgen-lowering therapies. These are primarily for treating prostate cancer. As an oral tablet, it allows for home administration rather than frequent hospital visits for injections. This significantly enhances convenience. The medicine is taken orally, typically once a day, and should be taken on an empty stomach.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF ABIRAPRO 250 MG?

Some of the possible side effects of Abirapro250 mg are:

1. High blood pressure

2. Swelling in the legs

3. Low potassium levels

4. Fatigue

5. Nausea or digestive issues

6. Changes in liver function

Conclusion: Abirapro 250 mg is a crucial hormonal therapy medication primarily used in combination with prednisone to treat advanced, metastatic castration-resistant prostate cancer (mCRPC) and high-risk metastatic hormone-sensitive prostate cancer (mHSPC) in adult men.

FREQUENTLY ASKED QUESTIONS:

Can Abirapro 250 mg cure prostate cancer?

Abirapro 250 mg is a type of hormone therapy used to manage prostate cancer, but it is not a cure. It works by stopping the body from producing testosterone. This can slow the growth of cancer cells. It also helps to control symptoms and aids in living longer.

How long should Abirapro be taken?

Abirapro 250 mg is generally taken long-term to manage advanced prostate cancer. Treatment typically continues as long as the medication is effective and the side effects are manageable.

What happens if a dose is missed?

If you miss a dose of Abirapro 250 mg, the body’s level can drop below a therapeutic range. This decrease can make it less effective at controlling your condition.

Can it be taken with food?

It can generally be taken with or without food. However, taking it with food may help reduce the chance of stomach upset.

ALSO READ

  1. https://www.truemeds.in/medicine/abiratas-250-mg-tablet-120-tm-tacr1-000128
  2. https://www.hexahealth.com/blog/prostate-cancer-treatment-in-india

3. https://www.cancerresearchuk.org/about-cancer/prostate-cancer

4. https://www.healthline.com/health/prostate-cancer/prostate-cancer-medication

, , , ,

Leave a comment

 

 

Add to cart